C12Y 207/0705
Mrna guanylyltransferase
Official title: mRNA guanylyltransferase (2.7.7.50)
C12Y207/0705 (Mrna guanylyltransferase) appears on 21 US grants and 29 published applications in this corpus.
Search patents in C12Y- Granted patents
- 21
- Published applications
- 29
- Assignees
- 18
- Inventors
- 68
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 2 |
| 2015 | 2 | 2 |
| 2016 | 1 | 0 |
| 2017 | 1 | 2 |
| 2018 | 1 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 1 |
| 2021 | 3 | 1 |
| 2022 | 1 | 4 |
| 2023 | 4 | 5 |
| 2024 | 2 | 4 |
| 2025 | 4 | 3 |
| 2026 | 1 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Modification of RNA-related enzymes for enhanced production17 Mar 2026US 12,577,600 B2Translate Bio, Inc.
- Compositions, kits, and methods for in vitro transcription9 Dec 2025US 12,492,420 B2
- Method for large-scale synthesis of long-chain RNA and method for site-specific modification of long-chain RNA28 Oct 2025US 12,454,712 B2ShenZhen Rhegen Biotechnology Co., Ltd.
- Enzyme based system for production of messenger RNA with increased transfection efficiency21 Oct 2025US 12,448,638 B2ImmunityBio, Inc.
- Vaccinia capping enzyme compositions and methods27 May 2025US 12,312,610 B2New England Biolabs, Inc.
- An affinity agent comprising a ligand that binds vce and comprises seq id no: 120 Aug 2026US 2026/0242756 A1Repligen Corporation
- Enzyme Based System for Production of Messenger RNA with Increased Transfection Efficiency23 Apr 2026US 2026/0110010 A1ImmunityBio, Inc.
- Compositions, kits, and methods for in vitro transcription2 Oct 2025US 2025/0305019 A1New England Biolabs, Inc.
- Compositions and methods relating to engineered rna polymerases with capping enzymes11 Sep 2025US 2025/0283060 A1Board of Regents, The University of Texas System
- Fce mrna capping enzyme compositions, methods and kits6 Mar 2025US 2025/0075193 A1New England Biolabs, Inc.
Most cited
By later US patents
- Enzymes and polymerases for the synthesis of RNA119US 9,512,456 B2ModernaTX, Inc. · 2016
- Kits and methods for generating 5′ capped RNA108US 8,846,348 B2Cellscript, LLC · 2014
- Kits and methods for generating 5′ capped RNA51US 9,005,930 B2Cellscript, LLC · 2015
- Enzymes and polymerases for the synthesis of RNA25US 9,790,531 B2ModernaTX, Inc. · 2017
- Kits and methods for generating 5′ capped RNA17US 9,115,380 B2Cellscript, LLC · 2015